Atlas Trials

CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

Clinical trial NCT05704192 · UNKNOWN

Trial details

NCT number
NCT05704192
Sponsor
Zhongda Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular CarcinomaPortal Hypertension
Start date
2023-05-04
Primary completion
2023-06-30
Enrollment
373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.